NLRP3 and Duchenne muscular dystrophy: This hypothesis is supported by various studies that have demonstrated that IL1β, after being activated by NLRP3 inflammasome, plays a crucial role in the onset and disease progression of several myopathies [19], such as myositis [20], sarcopenia [21] and Duchenne muscular dystrophy [22,23].